Category: Success Stories

TxtSquad: Built in Newfoundland, Scaling Canadian Innovation in Healthcare

At Bounce Health Innovation, we’re proud to spotlight companies that prove how made-in-Newfoundland solutions can strengthen healthcare across the country. TxtSquad, a St. John’s–based HealthTech company, is doing exactly that, expanding its proven patient engagement platform from Newfoundland and Labrador into Ontario.

Born in Newfoundland and developed in partnership with NL Health Services, TxtSquad is eliminating “hold music” from patient care through an AI-powered communication platform that helps clinics reduce no-shows, cut call volumes, and improve access to care. After demonstrating measurable success in public healthcare, TxtSquad is now scaling its impact to support healthcare teams in Ontario, showing that homegrown innovation can solve some of Canada’s biggest healthcare challenges.

In Newfoundland and Labrador, the scale of missed appointments is staggering, with hundreds of thousands each year costing the system millions. TxtSquad has already managed more than 115,000 appointments for over 36,000 patients, proving that better communication directly translates to more efficient care. The company projects that full provincial adoption could prevent more than 100,000 missed appointments annually in Newfoundland and Labrador alone.

TxtSquad’s expansion marks an important milestone for Canada’s healthcare ecosystem, demonstrating that Canadian-built, privacy-compliant (PIPEDA/PHIPA) digital tools can deliver scalable, accessible, and secure solutions for patients and providers alike.

At Bounce, we’re proud to have supported TxtSquad’s growth journey as they continue to turn local success into national impact. Their expansion into Ontario highlights how innovation developed here in Atlantic Canada can play a vital role in strengthening healthcare across the country.

Learn more about TxtSquad’s national expansion here.

Nucliq Biologics: Empowering Women’s Health with Gutcheck VIVO

At Bounce Health Innovation, we celebrate visionary companies that are reshaping healthcare in bold, transformative ways. One such company is Nucliq Biologics, a Newfoundland-based health tech firm that is pioneering personalized wellness for women through groundbreaking microbiome science.

Nucliq’s latest innovation, Gutcheck VIVO, is the first gut microbiome test designed specifically for women. Developed by a team of women scientists, Gutcheck VIVO offers personalized insights into how a woman’s gut health influences hormonal balance, mood, skin, metabolism, and more. This at-home test provides actionable recommendations to help women optimize their health and well-being.

The launch of Gutcheck VIVO marks a significant milestone for Nucliq Biologics, highlighting their commitment to advancing women’s health through cutting-edge science. By focusing on the unique needs of women, Nucliq is empowering individuals to take control of their health with personalized, science-backed insights.

At Bounce, we are proud to support Nucliq Biologics as they continue to lead the way in integrating microbiome science into women’s health. Their work exemplifies how Atlantic Canadian innovation is shaping the future of personalized medicine, not just in our region, but globally.

For more information on Gutcheck VIVO and to order your test, visit mygutcheck.ca

DischargeHUB: Transforming Patient Transitions with Seamless Discharge Planning

At Bounce Health Innovation, we spotlight trailblazing companies that are reshaping healthcare delivery. One such company is DischargeHUB, a Canadian innovator dedicated to enhancing patient flow and optimizing discharge processes across the healthcare continuum.

DischargeHUB offers a comprehensive solution that streamlines the discharge process for patients transitioning from hospital to home. By integrating care coordination, task management, and communication tools, DischargeHUB ensures that all aspects of a patient’s discharge are efficiently managed. This approach not only accelerates the discharge process but also improves patient outcomes by reducing delays and enhancing the quality of care during the transition period.

In Newfoundland and Labrador, DischargeHUB has partnered with NL Health Services to pilot its platform at the Health Sciences Centre and St. Clare’s Mercy Hospital in St. John’s. This six-month pilot focuses on patients who are medically ready to be discharged but require additional support at home, such as home care services or medical equipment. The goal is to facilitate a “home first” approach, allowing patients to recover in the comfort of their own homes while ensuring they receive the necessary care and support.

The collaboration with NL Health Services aligns with the province’s commitment to improving patient flow and reducing alternative level of care (ALC) days. By optimizing discharge planning, DischargeHUB helps free up hospital beds for patients who require acute care, thereby enhancing the overall efficiency of the healthcare system.

Furthermore, DischargeHUB’s partnership with the CAN Health Network underscores its potential for broader application across Canada. Through this collaboration, DischargeHUB aims to expand its reach and impact, bringing its innovative solutions to healthcare providers nationwide.

At Bounce, we are excited to support DischargeHUB as it continues to lead the way in transforming patient transitions and discharge planning. Their work exemplifies how Canadian innovation is driving improvements in healthcare delivery, ensuring that patients receive timely, coordinated, and compassionate care during one of the most critical phases of their healthcare journey.

For more information on DischargeHUB and their innovative solutions, visit their official website.

Granville Biomedical: Expanding Access to Women’s Health Education Worldwide

At Bounce Health Innovation, we celebrate visionary companies that are reshaping healthcare in bold, transformative ways. One of those success stories is Granville Biomedical, a Newfoundland and Labrador-based company that is breaking new ground in women’s health education—now reaching over 28 countries around the world.

Founded with a clear mission to improve access to high-quality educational tools for women’s health, Granville Biomedical designs anatomically accurate pelvic health models that empower healthcare professionals and patients alike. What began as a small effort to address gaps in clinical training has evolved into a global operation, with their products now used by institutions, educators, and healthcare practitioners worldwide.

Granville Biomedical’s flagship products, including the Venus Diversity Trio and the Iris Pessary & Device Demonstration Model, provide realistic, inclusive representations of anatomy in varying skin tones and for diverse patient populations. These models enable clinicians to practice procedures, demonstrate devices, and educate patients in ways that are both accurate and accessible—helping to destigmatize topics that are often overlooked.

This innovation is making a tangible impact. Healthcare providers from universities to clinics are integrating Granville’s models into training and patient care programs, enhancing clinical confidence and improving patient outcomes. By offering tools that are anatomically precise and culturally inclusive, Granville Biomedical is equipping healthcare professionals with the resources to provide high-quality, equitable care—whether they are in St. John’s, Birmingham, or beyond.

Closer to home, Granville Biomedical is helping to strengthen education and awareness around women’s health across Newfoundland and Labrador. Their success demonstrates the potential of Atlantic Canadian innovation to not only fill local gaps but also influence global healthcare practices.

In 2025, Granville Biomedical celebrated a major milestone: their expansion into 28 countries. This growth reflects both the demand for their high-quality educational tools and the company’s commitment to advancing women’s health on an international scale. It’s a testament to how a local vision can have a worldwide impact.

At Bounce, we’re proud to support Granville Biomedical as they continue to empower healthcare providers, educators, and patients around the globe. Their work is a shining example of how Atlantic Canadian innovation is shaping the future of medicine—not just in our region, but internationally.

Avalon Holographics: Bringing Holographic Visualization into Clinical Practice

At Bounce Health Innovation, we’re proud to spotlight companies turning advanced technology into practical tools for healthcare. Avalon Holographics is doing exactly that, demonstrating how true 3D visualization can transform the way clinicians plan, collaborate, and communicate.

This past August, Avalon welcomed a clinical team from Mayo Clinic in Florida to Orlando for a live demonstration of NOVAC, Avalon’s headset-free 3D holographic display. Hosted as part of the Berg Innovation Exchange, the session showcased how holographic visualization can support some of medicine’s most complex imaging and planning needs, from cellular structures to full cardiac systems.

By converting medical imaging and datasets into shared, spatially accurate holograms, NOVAC allows clinicians to view anatomy exactly as it exists in the body, rather than interpreting it through flat screens. This capability enhances surgical planning, supports interdisciplinary collaboration, and opens new possibilities for medical education.

Beyond clinical teams, holographic visualization also has the power to reshape the patient experience. With Avalon’s displays, patients and families can see and understand medical conditions in true 3D, making complex diagnoses more intuitive and improving informed decision-making. It’s a shift from explaining care to truly showing it.

Avalon’s work with Mayo Clinic reflects growing global interest in immersive visualization tools that bridge the gap between advanced data and human understanding. It’s a strong example of how Newfoundland and Labrador-based innovation is contributing to the future of patient-centred, collaborative care.

At Bounce, we’re proud to support Avalon Holographics as they continue to reimagine how medical data is experienced, understood, and applied in real clinical settings.

Learn more about Avalon’s holographic display technology and NOVAC:
👉 https://avalonholographics.com/medical/

Luxsonic: Transforming Healthcare Through Immersive Technology

At Bounce Health Innovation, we celebrate visionary companies that are reshaping healthcare in bold, transformative ways. One such company is Luxsonic Technologies Inc., a Canadian leader in immersive medical imaging solutions. Building upon their innovative SieVRt platform, Luxsonic is now collaborating with the CAN Health Network and the Virtual Health Hub to enhance healthcare delivery in Saskatchewan’s remote and Indigenous communities.

In August 2025, Luxsonic joined forces with the CAN Health Network and the Virtual Health Hub to address healthcare challenges in underserved regions. The partnership introduces two groundbreaking initiatives: Luxsonic’s Virtual Imaging Platform, a full-stack radiology workflow software built in virtual reality that allows radiologists to remotely view and interpret diagnostic images, and Virtual Hallway’s digital consultation platform, which enables family physicians to consult with specialists more quickly. Together, these tools improve access to expertise and accelerate diagnoses in areas where imaging specialists are often limited.

Luxsonic’s SieVRt platform, authorized as a Class II medical device in Canada, integrates viewing, workflow management, communication, AI-enhanced tools, and teaching resources into a single system. By replacing traditional workstations and monitors with high-definition virtual imaging displays, SieVRt offers a portable and cost-effective solution for remote radiology, empowering healthcare providers with innovative tools to deliver better care.

This collaboration reflects a shared commitment to improving access, equity, and health outcomes for northern and Indigenous populations. As Dr. Dante Morra, Chair and Founder of the CAN Health Network, notes, “We’re not just solving challenges—we’re building a more connected and inclusive health system that truly reflects the needs of Canadians.” With the Virtual Health Hub set to be fully operational by February 2027, Luxsonic’s involvement highlights their dedication to bridging healthcare gaps through cutting-edge technology.

At Bounce, we are proud to support Luxsonic Technologies as they continue to lead the way in integrating virtual reality into healthcare, making a tangible impact on communities in need.

Founded in 2016 by Dr. Mike Wesolowski, Luxsonic was built with a clear mission: to improve access to healthcare through cutting-edge tools like virtual reality (VR), augmented reality (AR), and mixed reality (MR). What began as an idea to modernize medical imaging education has evolved into a powerful suite of solutions with global reach and real-world impact.

Luxsonic’s flagship product, SieVRt, is an all-in-one virtual reality radiology suite. It enables radiologists to review and interpret medical imaging in an immersive 3D environment—completely untethered from traditional clinical workstations. By moving the reading room into virtual space, SieVRt makes it possible for healthcare professionals to collaborate remotely, train in realistic environments, and expand radiology services to underserved and remote regions. It’s a meaningful leap forward in both efficiency and accessibility.

This technology isn’t just hypothetical—it’s already making a difference. Luxsonic has partnered with some of the world’s most respected medical institutions, including Massachusetts General Hospital, where they’re working to integrate VR technologies directly into clinical care. In partnership with Queen’s University, they’ve also launched a remote radiology residency program that connects trainees in Canada with providers in Nairobi, Kenya, helping build capacity where it’s needed most.

Closer to home, Luxsonic’s work is helping to strengthen the healthcare system across Newfoundland and Labrador. In collaboration with NL Health Services, Luxsonic is working to bring its Virtual Imaging Platform into practice to improve access to radiology expertise across the province—bridging geography with immersive tech.

In 2022, Luxsonic’s momentum was recognized when they won the Startup TNT Investment Summit V Finale, unlocking new resources to grow their team and expand operations across Canada and the United States. It was a significant milestone that validated both their vision and their ability to scale impact through innovation.

At Bounce, we’re thrilled to support Luxsonic’s journey as they redefine how healthcare can be taught, accessed, and delivered. Their work is a shining example of how Atlantic Canadian innovation is shaping the future of medicine—not just in our region, but around the world.

PragmaClin: Revolutionizing Parkinson’s Care from Newfoundland and Labrador

At Bounce Health Innovation, we are proud to support trailblazing companies that are reshaping healthcare through innovative solutions. One of our standout success stories is PragmaClin Research Inc.—a health tech company based in St. John’s, Newfoundland and Labrador—that’s turning heads with its groundbreaking approach to neurological care, starting with Parkinson’s Disease.

Founded in 2020 by Memorial University PhD student Bronwyn Bridges and Parkinson’s patient advocate Gord Genge, PragmaClin was built from both lived experience and academic insight. Together, they set out to address one of the most significant gaps in Parkinson’s care: timely, accurate, and accessible patient assessments. From that mission, PRIMS® (Parkinson’s Remote Interactive Monitoring System) was born.

PRIMS® is a digital clinical tool that uses 3D depth camera technology and clinical-grade assessments to remotely evaluate motor symptoms in people with Parkinson’s Disease. The system produces real-time reports for healthcare providers, allowing for more frequent and accurate monitoring—without requiring patients to travel long distances to see a specialist. For a province like Newfoundland and Labrador, where geography often limits access to care, this kind of innovation is a game changer.

The system aligns with the Movement Disorder Society’s Unified Parkinson’s Disease Rating Scale (MDS-UPDRS), ensuring it meets global clinical standards. It’s designed to improve treatment plans, reduce healthcare costs, and—most importantly—enhance quality of life for patients and their families. PragmaClin’s user-first approach centers the lived experience of those managing chronic neurological conditions, offering a tech-enabled solution that’s both compassionate and clinically rigorous.

The team’s work hasn’t gone unnoticed. In 2022, PragmaClin received the Trico Foundation’s NU Community Board Award, recognizing them as one of Canada’s top emerging social enterprises. The award celebrates student-led ventures that are delivering meaningful social impact through innovation and entrepreneurship—something PragmaClin exemplifies.

Looking ahead, the company is focused on validating its technology in clinical settings, securing regulatory approvals, and expanding its reach across Canada and beyond. Their goal is to bring accessible, efficient, and personalized care to everyone living with Parkinson’s Disease, no matter where they are.

At Bounce, we’ve had the privilege of supporting PragmaClin’s journey from early-stage research to a scalable, purpose-driven company. Their story is a powerful reminder of what’s possible when innovation is rooted in real-world challenges and driven by a commitment to making healthcare better for everyone.